South Africa’s Central Bank Rules Out Financing Government
South Africa's central bank ruled out helping the government fund its runaway budget deficit by paying for its spending through loans, as the ruling party debates using the institution to fund infrastructure and development.
“We do not think it is prudent to finance government directly,” Kuben Naidoo, a Reserve Bank deputy governor, said on a conference call hosted by money manager Ninety One. “It would increase inflation risks. It would blur the lines between an independent central bank and publicly-elected office bearers. If we were to finance government directly, there would be no pressure on government to manage their costs in any way.”
The idea of monetary financing -- where the central bank buys debt directly from the government -- has been touted by Willem Buiter, a former Bank of England policy maker and Citigroup Inc. chief economist, as a potential solution for developed economies pouring money into the Covid-19 fight. Doing this, though, said Naidoo, removes the central bank's role in ensuring the government remains disciplined in its spending and could mean the “entire system crumbles.”
Read more: South Africa Budget Cuts Challenging Due to Virus, Masondo Says
Finance Minister Tito Mboweni, who has forecast the budget deficit could swell to more than 10% of gross domestic product, said in a tweet on Tuesday that he stands by the central bank's independence.
The comments come after Enoch Godongwana, the African National Congress's head of economic transformation, suggested that the bank help finance development through the creation of a 500 billion-rand ($29 billion) fund, while Deputy Finance Minister David Masondohas said he would support direct central bank purchases of government debt.
The central bank in March started buying government bonds in the secondary market as the pandemic and plunging oil prices sent stocks, bonds and other asset prices into turmoil. The Reserve Bank is insisting that the aim of that intervention was to reduce dysfunctionality in the market caused by concerns over Covid-19, rather than an attempt at quantitative easing.
“There is a limit to central bank purchases, especially if you are an emerging market,” Governor Lesetja Kganyago said in a webinar organized by the South African Chamber of Commerce in London. The likes of the U.S., U.K. and Japan can embark on quantitative easing “with the knowledge that their currencies are reserve currencies and because they are reserve currencies, people will continue to hold them.”
Read more: South Africa's Kganyago Sees Limit to Central Banks' Virus Role
The central bank has more than doubled its holdings of government securities to 20.64 billion rand ($1.2 billion) in April, helping to reduce borrowing costs in the domestic bond market. It has also cut its benchmark repurchase rate and relaxed accounting and capital rules to release additional money for lending. The economy could contract the most in at least four decades due to shocks caused by the virus and a lockdown to curb its spread.
‘Walked Away'
Even so, the Reserve Bank's critics accuse it of not doing enough to support the economy and some members in the ANC have called for its nationalization.
While Kganyago has in the past warned that a nationalizaion would be protracted and expensive and could be used as a “Trojan horse” to reopen the debate about the institution's role, he said Tuesday the central bank has “walked away” from the debate. It will instead focus on executing its mandate of maintaining price stability.
Read more: South Africa's ANC Mulls Using Pensions, Central Bank For Growth
Another policy mooted by the ANC, that of forcing pension funds and money managers to invest in government securities, also didn't find resonance with Naidoo, who serves as the chief executive officer of the Prudential Authority, which oversees banks and life insurers.
“Prescribed assets doesn't work,” Naidoo said, adding that it his personal view and not that of the central bank. “If you force someone to buy something, then they won't buy it. They will find every way of not buying it.”
©2020 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.